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Only a perennial holiday on a lonely island could excuse a scientist for not being aware that CD4 + regulatory T (T reg ) cells are now considered to be key players in the maintenance of immunological homeostasis, prevention of autoimmune diseases, and fine-tuning of immune responses against invading pathogens. The T reg cell compartment is composed of cells that commit to the T reg cell lineage when expression of the gene encoding the "master switch" transcription factor Foxp3 is induced either in the thymus during T cell development or in the periphery after naïve conventional T cells are stimulated under tolerogenic conditions, which gives rise to natural or induced Foxp3-positive (Foxp3 + ) T reg cells, respectively (1) . The molecular requirements for the control of Foxp3 expression have been intensely studied, and permanent Foxp3 expression is required to maintain the transcriptional and functional program established during T reg cell development (2) . Although distinct epigenetic modifications of the Foxp3 locus contribute to the stabilization of Foxp3 expression and thereby to fixing the T reg cell phenotype (3, 4) , the flexibility and plasticity of T reg cells is still controversial (5, 6) . Furthermore, little is known so far about the precise nature of the events initiating Foxp3 expression in developing T reg cells. Liu and colleagues have now demonstrated that this early step of T reg cell development is strictly controlled by epigenetic mechanisms (7) . The small ubiquitin-like modifier protein (SUMO) E3 ligase PIAS1 specifically binds to the Foxp3 promoter and recruits chromatin-remodeling enzymes, such as DNA methyltransferases, and thereby represses the induction of Foxp3 expression in non-T reg cells; all of this suggests that specific signals removing PIAS1 from the Foxp3 promoter are required to initiate the development of Foxp3 + T reg cells. Expression of the Foxp3 gene is controlled by its promoter, which is located 6.5 kb upstream of the first coding exon and is activated in response to signaling through the T cell receptor (TCR) and interleukin-2 (IL-2) receptor through binding of NFAT (nuclear factor of activated T cells), AP1 (activator protein 1), and STAT5 (signal transducer and activator of transcription 5) (8) . The transcriptional activity of the Foxp3 promoter is supported by several evolutionarily conserved noncoding DNA sequence (CNS) elements at the Foxp3 locus ( Fig. 1) , which encode information on the size and stability of the T reg population and which are subject to epigenetic modifications (3, 9) . CNS1 is associated with acetylated histones in Foxp3 + T reg cells and can be regarded as a transforming growth factor-β (TGF-β) sensor element, which plays a prominent role in the generation of induced T reg cells in response to TGF-β signaling by binding of the TGF-β-induced transcription factor SMAD3 (mothers against decapentaplegic homolog 3) (9, 10) . Permissive histone modifications also accumulate at CNS2 (9, 11) . However, the most remarkable epigenetic modifications at CNS2 were observed at the level of DNA methylation (11) (12) (13) (14) : This element is fully methylated in conventional T cells and demethylated exclusively in T reg cells and, thus, is named T reg cell-specific demethylated region (TSDR). Cumulative evidence indicates that the TSDR does not act as an on-off switch, but rather seems to be required for the stabilization of Foxp3 expression in T reg cells (3, 9) . CNS3, although it displays no enhancer activity, acts as a pioneer element that initiates Foxp3 transcription and, thus, plays a prominent role in the generation of both natural and induced Foxp3 + T reg cells (9) . Foxp3 + T reg cells can differentiate during T cell development in the thymus at the stage of CD4 + (single-positive, SP) thymocytes (15) . At this stage, positive selection and commitment to the CD4 + T helper cell lineage has already occurred, and thymocytes with a potentially self-reactive TCR are either deleted by the induction of apoptosis (negative selection) or diverted into the T reg cell lineage (16) . Antigen presentation by medullary antigen-presenting cells (APCs, namely medullary thymic epithelial cells and dendritic cell subsets) is sufficient to induce Foxp3 expression in developing thymocytes (17, 18) . However, the signals (T cell intrinsic or APC-derived) that promote or block T reg cell development have been incompletely studied so far (19) . The picture changed with the study by Liu et al., which showed that PIAS1 inhibits the early steps of T reg cell development (7). In both immature CD4 + CD8 + (double-positive) thymocytes, as well as in more mature Foxp3 -CD25 -CD4SP thymocytes that did not differentiate into the T reg cell lineage, PIAS1 binds to the Foxp3 promoter and recruits DNA methyltransferases and other chromatin-modifying proteins, such as HP1 (heterochromatin protein 1), which keep the Foxp3 promoter in a largely methylated, inaccessible, and silent state ( Fig. 2A) . In accordance with the role of PIAS1 as an epigenetic repressor, cells from Pias1 -/-mice show reduced DNA methylation at the Foxp3 promoter and increased numbers of Foxp3 + T reg cells (7) . Thymic T reg cell differentiation is a multistep process, initiated by TCR signals that induce increased surface abundance of the IL-2 receptor α chain (CD25) on CD4SP thymocytes, which renders them responsive to subsequent cytokine signaling (20 cells in the presence of IL-2 without further need for TCR signaling (Fig. 2A) . Expression of Foxp3 is enhanced by the release of PIAS1 from the Foxp3 promoter (7); however, it remains obscure at precisely which stage and through which specific signals PIAS1 release is induced. One plausible scenario is that removal of PIAS1 from the Foxp3 promoter is part of the initial T reg cell-differentiation program induced by TCR signals and that the promoter then becomes accessible for binding of phosphorylated STAT5 as a downstream mediator of signaling by IL-2 and additional transcription factors such as NFAT (7, 21) . Alternatively, APCs in the thymic medulla may also provide hitherto unknown TCRindependent signals that induce the release Antigen-specific effector T cell A A t Ant Ant Ant Ant Ant Ant A ige ige ige ige ige ige ige ige gen-s n-sn-s n-s n-s n-spec pec pec pec pec pe pe p p ific ific ific ific ific ific ific fi ff effe effe effe effe effe effe effe eff ff t cto cto cto cto cto ctor T r T r T r T r T r T r T r ce ce ce c ce ce e ell ll ll ll ll ll l -/-mice (7). After demethylation of the TSDR, this stabilizer element becomes accessible to transcription factors like Ets-1 (E26-AMV virus oncogene cellular homolog 1) and CREB (cyclic adenosine monophosphate response element-binding protein), among others (12, 22, 23) . The mechanistic details of how sustained Foxp3 expression is mediated by the demethylated TSDR and associated transcription factors are currently under investigation.
The detailed characterization of Foxp3 + T reg cells has opened up exciting opportunities for immune intervention with T reg cell-based therapeutics in autoimmunity, allergy, graft-versus-host disease, and allotransplantation. Because T reg cells can act in an antigen-specific manner, the conversion of pathogenic effector T cells into antigenspecific Foxp3 + T reg cells is the most favorable strategy, as it would leave intact protective immunity directed against invading pathogens. However, this strategy is hampered by the resistance of effector T cells to TGF-β-mediated conversion into Foxp3 + cells and by the autocrine effects of inflammatory cytokines (such as interferon-γ, IL-4, and IL-21), which are partially responsible for this resistance (24) (25) (26) (27) (28) (29) (30) (31) . It is tempting to speculate that epigenetic repression of the Foxp3 promoter by PIAS1 also contributes to the prevention of Foxp3 induction in effector T cells, because promoter methylation is increased upon in vitro activation of conventional T cells (12) , which might further restrict the accessibility of the promoter and prevent the induction of Foxp3 expression in effector T cells. Thus, strategies inducing the selective release of PIAS1 from the Foxp3 promoter combined with directed induction of TSDR demethylation might foster the conversion of pathogenic effector T cells into stable, antigen-specific Foxp3 + T reg cells (Fig. 2B) . In view of the potential clinical applications of Foxp3 + T reg cells, it remains an important challenge to more precisely elucidate the combination of signals that induce the selective opening of the Foxp3 locus through epigenetic alterations at its various elements during development of Foxp3 + T reg cells in the thymus.
